Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neostigmine

"Neostigmine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.


This graph shows the total number of publications written about "Neostigmine" by people in Harvard Catalyst Profiles by year, and whether "Neostigmine" was a major or minor topic of these publication.
Bar chart showing 27 publications over 13 distinct years, with a maximum of 3 publications in 2015 and 2018 and 2019 and 2020
To see the data from this visualization as text, click here.
Related Networks
People
Explore
_
Similar Concepts
_
Top Journals 
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.